OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002840$136000.0055

Miwon Commercial Co Ltd

Specialty ChemicalsVerified

Miwon Commercial maintains a strong liquidity position, with a current ratio of 4.93 and cash and equivalents of KRW 26.49 billion, indicating robust short-term financial flexibility. The company's debt-to-equity ratio is effectively zero, reflecting a conservative capital structure with no long-term debt obligations. This liquidity profile is further supported by a free cash flow of KRW 25.68 billion, which provides flexibility for reinvestment or shareholder returns. Profitability metrics show that Miwon Commercial is performing well relative to industry norms. The company's return on equity (ROE) of 10.45% and return on assets (ROA) of 8.83% are strong indicators of efficient capital utilization and asset management. These returns are well above the typical thresholds for the specialty chemicals industry, suggesting a competitive advantage in cost control and operational efficiency. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to sector-specific risks, such as demand fluctuations in the industrial and manufacturing markets it serves. Looking ahead, Miwon Commercial is projected to maintain a stable growth trajectory, with no significant revenue changes expected in the next fiscal year. The company's operating cash flow of KRW 68.59 billion and strong net income of KRW 43.52 billion support this outlook, although the absence of capital expenditure data beyond the current year limits visibility into long-term growth initiatives. The company's risk profile is low, with no immediate liquidity or dilution concerns identified in the risk assessment. The absence of long-term debt and the presence of substantial cash reserves reduce financial leverage risk. Additionally, the company has not issued any recent dilutive securities, and no dilution pressure is expected in the near term. Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly alter the company's financial trajectory. The company's financial statements remain consistent with prior periods, and no new regulatory or operational risks have been disclosed.

30-day price · 002840+4900.00 (+3.7%)
Low$130200.00High$153300.00Close$136000.00As of15 May, 00:00 UTC
Profile
CompanyMiwon Commercial Co Ltd
Ticker002840.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Miwon Commercial Co Ltd is a South Korean specialty chemicals company that produces and distributes chemical products, primarily serving industrial and manufacturing sectors.

Classification. Miwon Commercial is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Miwon Commercial maintains a strong liquidity position, with a current ratio of 4.93 and cash and equivalents of KRW 26.49 billion, indicating robust short-term financial flexibility. The company's debt-to-equity ratio is effectively zero, reflecting a conservative capital structure with no long-term debt obligations. This liquidity profile is further supported by a free cash flow of KRW 25.68 billion, which provides flexibility for reinvestment or shareholder returns. Profitability metrics show that Miwon Commercial is performing well relative to industry norms. The company's return on equity (ROE) of 10.45% and return on assets (ROA) of 8.83% are strong indicators of efficient capital utilization and asset management. These returns are well above the typical thresholds for the specialty chemicals industry, suggesting a competitive advantage in cost control and operational efficiency. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to sector-specific risks, such as demand fluctuations in the industrial and manufacturing markets it serves. Looking ahead, Miwon Commercial is projected to maintain a stable growth trajectory, with no significant revenue changes expected in the next fiscal year. The company's operating cash flow of KRW 68.59 billion and strong net income of KRW 43.52 billion support this outlook, although the absence of capital expenditure data beyond the current year limits visibility into long-term growth initiatives. The company's risk profile is low, with no immediate liquidity or dilution concerns identified in the risk assessment. The absence of long-term debt and the presence of substantial cash reserves reduce financial leverage risk. Additionally, the company has not issued any recent dilutive securities, and no dilution pressure is expected in the near term. Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly alter the company's financial trajectory. The company's financial statements remain consistent with prior periods, and no new regulatory or operational risks have been disclosed.
Key takeaways
  • Miwon Commercial has a strong liquidity position with a current ratio of 4.93 and no long-term debt.
  • The company's ROE of 10.45% and ROA of 8.83% indicate efficient capital and asset utilization.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • The company is projected to maintain stable growth with no significant revenue changes expected.
  • Risk factors are low, with no immediate liquidity or dilution concerns identified.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$441.14B
Gross profit$85.62B
Operating income$43.55B
Net income$43.52B
R&D
SG&A
D&A
SBC
Operating cash flow$68.59B
CapEx-$49.25B
Free cash flow$25.68B
Total assets$492.89B
Total liabilities$76.51B
Total equity$416.38B
Cash & equivalents$26.49B
Long-term debt$182.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$441.14B$43.55B$43.52B$25.68B
FY-1$435.80B$50.06B$50.55B$24.54B
FY-2$421.37B$68.03B$61.02B$24.44B
FY-3$438.19B$77.08B$72.22B$50.83B
FY-4$359.79B$59.66B$57.74B$24.53B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$492.89B$416.38B$26.49B
FY-1$478.70B$400.46B$35.32B
FY-2$447.57B$377.97B$37.42B
FY-3$415.62B$341.85B$25.26B
FY-4$372.41B$295.99B$21.66B
PeriodOCFCapExFCFSBC
FY0$68.59B-$49.25B$25.68B
FY-1$79.54B-$49.72B$24.54B
FY-2$97.57B-$59.92B$24.44B
FY-3$70.78B-$41.41B$50.83B
FY-4$55.08B-$28.84B$24.53B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$117.30B$4.20B
FQ-1$108.59B$9.01B$12.77B$6.79B
FQ-2$111.21B$10.29B$7.32B$6.79B
FQ-3$108.23B$13.49B$13.08B$4.21B
FQ-4$108.23B$13.49B$13.08B$15.13B
FQ-5$114.64B$9.63B$13.51B$4.64B
FQ-6$106.17B$14.34B$10.76B$4.64B
FQ-7$111.06B$20.11B$17.75B$12.53B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$492.89B$416.38B$26.49B
FQ-1$481.19B$410.14B$18.42B
FQ-2$481.19B$407.60B$25.66B
FQ-3$482.19B$404.73B$33.73B
FQ-4$484.29B$404.73B$33.73B
FQ-5$462.42B$389.76B$29.03B
FQ-6$462.42B$389.76B$29.03B
FQ-7$461.34B$391.26B$26.66B
PeriodOCFCapExFCFSBC
FQ0$15.14B-$13.10B$4.20B
FQ-1$68.59B-$49.25B$6.79B
FQ-2$37.73B-$32.75B$6.79B
FQ-3$26.76B-$21.31B$4.21B
FQ-4$10.78B-$8.00B$15.13B
FQ-5$59.48B-$36.37B$4.64B
FQ-6$59.48B-$36.37B$4.64B
FQ-7$32.68B-$24.21B$12.53B
Valuation
Market price$136000.00
Market cap$617.44B
Enterprise value$591.13B
P/E14.2
Reported non-GAAP P/E
EV/Revenue1.3
EV/Op income13.6
EV/OCF8.6
P/B1.5
P/Tangible book1.5
Tangible book$416.38B
Net cash$26.31B
Current ratio4.9
Debt/Equity0.0
ROA8.8%
ROE10.4%
Cash conversion1.6%
CapEx/Revenue-11.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002840Activity
Op margin9.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin9.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin19.4%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-11.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:18 UTCJob: 9f571d72